Gastric acid hypersecretory states: recent insights and advances.
about
ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromesPrimary hepatic gastrinoma: an unusual case of zollinger-ellison syndrome.Italian Association of Clinical Endocrinologists (AME) position statement: a stepwise clinical approach to the diagnosis of gastroenteropancreatic neuroendocrine neoplasms.Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)Coleus forskohlii Extract Supplementation in Conjunction with a Hypocaloric Diet Reduces the Risk Factors of Metabolic Syndrome in Overweight and Obese Subjects: A Randomized Controlled Trial.Diagnosis of Zollinger-Ellison syndrome: increasingly difficult.Weight Gain in Zollinger-Ellison Syndrome After Acid Suppression.Pharmacotherapy of Zollinger-Ellison syndrome.Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advancesHistamine: an undercover agent in multiple rare diseases?Zollinger-Ellison syndrome: recent advances and controversies.Gastric Ulcer Complications after the Introduction of Proton Pump Inhibitors into Clinical Routine: 20-Year Experience.Chronic diarrhea and diffuse gastric wall thickening: What is the common link?Diagnosis of Zollinger-Ellison syndrome in the era of PPIs, faulty gastrin assays, sensitive imaging and limited access to acid secretory testing.Normal dogs treated with famotidine for 14 days have only transient increases in serum gastrin concentrations.What We Know and What We Need to Know about Aromatic and Cationic Biogenic Amines in the Gastrointestinal Tract
P2860
Q24603675-ADC22E42-B979-4089-8336-B935E221E77AQ33916256-5E96C042-DE29-4DF0-ACED-D15EA4016FD4Q34157385-BFA234C9-075C-4115-A7BC-E5B351B85198Q35760798-A0A8F6BB-492D-4B28-B69C-FB7438E9C4D9Q36329927-8BE15198-CE8B-420B-91CC-C9796B086031Q36351873-B9C680B8-4C7C-4D0B-808C-A3AC088F56DAQ36445705-458BAE3A-E5B2-403A-885E-1143894A256AQ36632665-6A1FAE5C-7E9F-4549-8D54-740754C4F1A3Q37125550-4A21F110-5C52-4757-AB03-2830F92ABA6AQ37995651-996595F1-8D8A-434D-B213-C6B6F32923A5Q38150165-DDE3CFDD-A116-485E-8651-51BB478EE237Q38635760-955FF488-7EFF-416C-AC9C-6C5565EE1DDBQ41585729-3181C745-7DC2-439E-A35D-9E7ACC9130E2Q50075239-2A2960F6-BE94-46CF-A6E1-AFC5D77819ACQ51365214-F6A62121-DAF3-448B-B59F-91C45E7F5794Q58764150-BA70B3E0-2FF8-48F6-A039-0DADA9A5B217
P2860
Gastric acid hypersecretory states: recent insights and advances.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Gastric acid hypersecretory states: recent insights and advances.
@en
Gastric acid hypersecretory states: recent insights and advances.
@nl
type
label
Gastric acid hypersecretory states: recent insights and advances.
@en
Gastric acid hypersecretory states: recent insights and advances.
@nl
prefLabel
Gastric acid hypersecretory states: recent insights and advances.
@en
Gastric acid hypersecretory states: recent insights and advances.
@nl
P2093
P2860
P1476
Gastric acid hypersecretory states: recent insights and advances.
@en
P2093
Nauramy Osefo
Robert T Jensen
Tetsuhide Ito
P2860
P2888
P304
P356
10.1007/S11894-009-0067-6
P577
2009-12-01T00:00:00Z